Munafa Stock Market Course + Intraday & FNO calls 
Glaxosmithkline Plc (GSK) Technical (Analysis) Reports Glaxosmithkline Plc ["Technical Analysis"] Reports -NYSE Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Glaxosmithkline Plc (GSK)
Technical Analysis Report for NYSE stock GSK Glaxosmithkline Plc. Dated: 22 May 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NYSE stock exchange
If you are looking for Tomorrow's Movement Predictions for NYSE stock GSK Glaxosmithkline Plc then click here. or read Experts views on Glaxosmithkline Plc or Forecast & share price targets of Glaxosmithkline Plc
Glaxosmithkline Plc Opened at 51.56 and Closed at: 51.38, which is -0.29% of previous session's close. It moved within a range of 51.13 and 51.80
The session was a Bearish session with an average volume of 3153700, which is 33.34% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- The stock has fallen, and its mid term trend is also negative and in a downtrend.
- Even though the stock has fallen, but its long term trend is positive and in an uptrend.
Support for tomorrow is 50.92 and resistance for tomorrow is 51.59
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 51.07, 50.77 resistance for tomorrow's hourly charts is 51.74, 52.11
10 Day SMA for Glaxosmithkline Plc (GSK) is 50.73 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Glaxosmithkline Plc (GSK) is 51.02 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Glaxosmithkline Plc (GSK) is 53.72 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 54.06 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Glaxosmithkline Plc is 49.02 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Glaxosmithkline Plc is at 51.02 and 200 DMA is at 49.02, while 50 DMA and 100 DMA are at 53.72 and 54.06 respectively
Glaxosmithkline Plc (GSK) moving average of 20 SMA is at 51.02 and 20 EMA is at 51.61
| Date | Closing Price | 20 SMA | 20 EMA |
| 22 Fri May | 51.38 | 51.02 | 51.61 |
| 21 Thu May | 51.53 | 51.16 | 51.63 |
| 20 Wed May | 50.78 | 51.31 | 51.64 |
| 19 Tue May | 51.05 | 51.55 | 51.73 |
| 18 Mon May | 50.26 | 51.78 | 51.8 |
| 15 Fri May | 49.67 | 52.07 | 51.96 |
Glaxosmithkline Plc (GSK) moving average of 50 SMA is at 53.72 and 50 EMA is at 53
| Date | Closing Price | 50 SMA | 50 EMA |
| 22 Fri May | 51.38 | 53.72 | 53 |
| 21 Thu May | 51.53 | 53.77 | 53.07 |
| 20 Wed May | 50.78 | 53.85 | 53.13 |
| 19 Tue May | 51.05 | 53.94 | 53.23 |
| 18 Mon May | 50.26 | 54.03 | 53.32 |
| 15 Fri May | 49.67 | 54.11 | 53.45 |
Glaxosmithkline Plc (GSK) moving average of 100 SMA is at 54.06 and 100 EMA is at 52.6
| Date | Closing Price | 100 SMA | 100 EMA |
| 22 Fri May | 51.38 | 54.06 | 52.6 |
| 21 Thu May | 51.53 | 54.03 | 52.62 |
| 20 Wed May | 50.78 | 54.01 | 52.64 |
| 19 Tue May | 51.05 | 53.99 | 52.68 |
| 18 Mon May | 50.26 | 53.97 | 52.71 |
| 15 Fri May | 49.67 | 53.96 | 52.76 |
Glaxosmithkline Plc (GSK) moving average of 200 SMA is at 49.02 and 200 EMA is at 49.6
| Date | Closing Price | 200 SMA | 200 EMA |
| 22 Fri May | 51.38 | 49.02 | 49.6 |
| 21 Thu May | 51.53 | 48.95 | 49.58 |
| 20 Wed May | 50.78 | 48.88 | 49.56 |
| 19 Tue May | 51.05 | 48.82 | 49.55 |
| 18 Mon May | 50.26 | 48.76 | 49.53 |
| 15 Fri May | 49.67 | 48.69 | 49.52 |
Glaxosmithkline Plc has performed better than Zoetis Inc in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Stryker Corporation has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Stryker Corporation, about 4.13% more returns!
Steris Plc has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Steris Plc, about 4.22% more returns!
Abbvie Inc has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Abbvie Inc, about 14.78% more returns!
Avanos Medical has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Avanos Medical, about 5.59% more returns!
Baxter International has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Baxter International, about 12.58% more returns!
Community Health has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Community Health, about 2.89% more returns!
Edwards Lifesciences has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Edwards Lifesciences, about 9.92% more returns!
Fresenius Medical has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Fresenius Medical, about 1.81% more returns!
Glaxosmithkline Plc has performed better than Globus Medical in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Haemonetics Corporation has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Haemonetics Corporation, about 15.11% more returns!
Glaxosmithkline Plc has performed better than Hca Healthcare in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Glaxosmithkline Plc has performed better than Herbalife Nutrition in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Humana Inc has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Humana Inc, about 39.72% more returns!
Glaxosmithkline Plc has performed better than Inspire Medical in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Iqvia Holdings has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Iqvia Holdings, about 11.28% more returns!
Eli Lilly has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Eli Lilly, about 27.55% more returns!
3m Company has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in 3m Company, about 10.06% more returns!
Arcus Biosciences has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Arcus Biosciences, about 0.15% more returns!
Glaxosmithkline Plc Technical analysis of indicators
Price action analysis of Glaxosmithkline Plc (GSK) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Glaxosmithkline Plc stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Glaxosmithkline Plc in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Glaxosmithkline Plc Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a buy signal for Glaxosmithkline Plc in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Glaxosmithkline Plc is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 50.7 and Glaxosmithkline Plc GSK stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Glaxosmithkline Plc GSK stock. Volume based technical analysis of Glaxosmithkline Plc GSK stock is negative.
Glaxosmithkline Plc Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NYSE stock GSK Glaxosmithkline Plc These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And GSK Experts View which covers a lot of information including buying and selling signals
GSK future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Glaxosmithkline Plc or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Glaxosmithkline Plc (GSK) Technical (Analysis) Reports Glaxosmithkline Plc ["Technical Analysis"] Reports -NYSE Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- NYSE Screeners
- NYSE Daily Screener
- NYSE Weekly Screener
- NYSE Monthly Screener
- Support & Resistance
- NYSE Shares Near Support
- NYSE Shares Near Resistance
